Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mazdutide Plus Levonorgestrel-Releasing Intrauterine System for Fertility-Sparing Treatment in Overweight or Obese Patients With Atypical Endometrial Hyperplasia or Early Endometrioid Endometrial Cancer

NCT07781150 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07781150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07781150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mazdutide Plus Levonorgestrel-Releasing Intrauterine System for Fertility-Sparing Treatment in Overweight or Obese Patients With Atypical Endometrial Hyperplasia or Early Endometrioid Endometrial Cancer
Lead sponsor
Tongji Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
June 30, 2031
Enrollment
128 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, endometrial carcinoma stage i, endometrioid endometrial cancer, obesity, overweight